AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017
Jan 10, 2017
30583_dirs_2017-01-10_3787a828-c067-4ddf-b87e-b2e0ea24f5fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-01-09
Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-09 | Common Stock | S | 5000 | $90.00 | Disposed | 18100 | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on November 16, 2016.
F2: All shares were sold at the same price.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19